Abstract
The discovery of endogenous opiatelike peptides brought to neuroscience research new techniques for studying behavior and the hope of increasing the responsiveness of some aspects of psychopathology to pharmacological manipulation. In addition, the similarity of opiate effects to the symptoms of several behavioral disorders raises the possibility that these disorders are associated with abnormalities in endorphin production, metabolism, or receptor function. The 20-year search for a role of catecholamines in affective illness and schizophrenia has been recapitulated in 5 short years of endorphin research.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Belluzzi, J. D., and Stein, L., 1977, Enkephalin may mediate euphoria and drive-reduction reward, Nature (London) 266: 556.
Buchsbaum, M. S., 1977, The middle evoked response components and schizophrenia, Schizophrenia Bull. 3: 93.
Buchsbaum, M. S., Davis, G. C., and Bunney, W. E., Jr., 1977, Naloxone alteration of pain perception and somatosensory evoked potentials in normal subjects, Nature (London) 270: 620.
Buchsbaum, M. S., Davis, G. C., Goodwin, F. K., Murphy, D. L., and Post, R. M., 1980, Psychophysical pain judgments and somatosensory evoked potentials in patients with affective illness and in normal adults, in: Clinical Neurophysiological Aspects of Psychopathological Conditions ( C. Perris, L. von Knörring, and D. Kemali, eds.), pp. 63–72, Karger, Basel.
Davis, G. C., Bunney, W. E., Jr., DeFraites, E. G., Kleinman, J. E., van Kammen, D. P., Post, R. M., and Wyatt, R. J., 1977, Intravenous naloxone administration in schizophrenia and affective illness, Science 197: 74.
Davis, G. C., Buchsbaum, M. S., and Bunney, W. E., Jr., 1979a, Analgesia to painful stimuli in affective illness, Am. J. Psychiatry 136: 1148.
Davis, G. C., Buchsbaum, M. S., and Bunney, W. E., Jr., 1979b, Research in endorphins and schizophrenia, Schizophrenia Bull. 5: 244.
Davis, G. C., Bunney, W. E., Jr., Buchsbaum, M. S., DeFraites, E. G., Duncan, W., Gillin, J. C., van Kammen, D. P., Kleinman, J., Murphy, D. L. Post, R. M., Reus, V., and Wyatt, R. J., 1979c, Use of narcotic antagonists to study the role of endorphins in normal and psychiatric patients, in: Endorphins in Mental Health Research ( E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.), pp. 393–406, Oxford University Press, London.
Davis, G. C., Buchsbaum, M. S., van Kammen, D. P., and Bunney, W. E., Jr., 1979d, Analgesia to pain stimuli in schizophrenics and its reversal by naltrexone, Psychiatry Res. 1: 61.
Davis, G. C., Buchsbaum, M. S., and Bunney, W. E., Jr., 1980, Alteration of evoked potentials link research in attention dysfunction to peptide responsive symptoms of schizophrenia, in: Neural Peptides and Neuronal Communications (E. Costa and M. Trabucchi, eds.),pp. 473–478, Raven Press, New York.
Desmedt, J. E., and Robertson, D., 1977, Differential enhancement of early and late components of the cerebral somatosensory evoked potentials during forced-paced cognitive tasks in man, J. Psychol. 271: 761.
de Wied, D., Bohus, B., van Ree, J. M., and Urban, I., 1978a, Behavioral and electrophysiological effects of peptides related to lipotropin (â-LPH), J. Pharmacol. Exp. Ther. 204: 570.
de Wied, D., Kovacs, G. L., Bohus, B., van Ree, J. M., and Greven, H. M., 1978b, Neuroleptic activity of th neuropeptide â-LPH62–77 ([des-Tyr1]-γ-endorphin; DTyE), Eur. J. Pharmacol. 49: 427.
Emrich, H. M., Cording, C., Pirée, S., Kölling, A., von Zerssen, D., and Herz, A., 1977, Indication of an antipsychotic action of the opiate antagonist naloxone, Pharmakopsychiatr. Neuro-Psychopharmakol. 10: 265.
Buchsbaum, M. S., 1977, The middle evoked response components and schizophrenia, Schizophrenia Bull. 3: 93.
Gessa, G. L., Paglietti, E., and Quarantotti, B. P., 1979, Induction of copulatory behavior in sexually inactive rats by naloxone, Science 204: 203.
Gispen, W. H., Wiegant, V. M., Bradbury, A. F., Holme, E. C., Smyth, D. G., Snell, C. R., and de Wied, D., 1976, Induction of excessive grooming in the rat by fragments of lipotropin, Nature (London) 264: 796
Gritz, E. R., Shiffman, S. M., Jarvik, M. E., Schlesinger, J., and Charuvastra, V. C., 1976, Naltrexone: Physiological and psychological effects of single doses, Clin. Pharmacol. Ther. 19: 773.
Gunne, L. M., Lindström, L., and Terenius, L., 1977, Naloxone-induced reversal of schizophrenic hallucinations, J. Neural Transm. 40: 13.
Hall, K. R. L., and Stride, E., 1954, The varying response to pain in psychiatric disorders: A study in abnormal psychology, Br. J. Med. Psychol. 27: 48.
Hillyard, S. A., Picton, T. W., and Regan, D., 1978, Sensation, perception and attention: Analysis using ERPs, in Event-Related Brain Potentials in Man ( E. Callaway, P. Tueting, and S. H. Koslow, eds.), pp. 223–320, Academic Press, New York.
Holtzman, S. G., 1975, Effects of narcotic antagonists on fluid intake in the rat, Life Sci. 16: 1456.
Janowsky, D., Judd, L., Huey, L., Roitman, N., Parker, D., and Segal, D., 1978, Naloxone effects on manic symptoms and growth hormone levels, Lancet 2: 320.
Kastin, A. J., Miller, L. H., Gonzalez-Barcena, D., Hawley, W. D., Dyster-Aas, K., Schally, A. V., and Velasco de Panra, M. L., 1971, Psychophysiologic correlates of MSH activity in man, Physiol. Behay. 7: 893.
Kyriakides, M., Silverstone, T., Jeffcoate, W., and Laurence, B., 1980, Effect of naloxone on hyperphagia in Prader—Willi syndrome, Lancet 1: 876.
Lipinski, J., Meyer, R., Kornetsky, C., and Cohen, B. M., 1979, Naloxone in schizophrenia: Negative result Lancet 1: 1292.
McCloy, J., and McCloy, R. F., 1979, Enkephalins, hunger, and obesity, Lancet 2: 156.
Malmo, R. B., and Shagass, C., 1949, Physiologic studies of reaction to stress in anxiety and early schizophrenia, Psychosom. Med. 11: 9.
Malmo, R. B., Shagass, C., and Smith, A. A., 1951, Responsiveness in chronic schizophrenia, J. Pers. 19: 359.
Marchand, W. E., 1955, Occurrence of painless myocardial infarction in psychotic patients, N. Engl. J. Med. 253: 51.
Marchand, W. E., Sarota, B., Marble, H. C., Leay, T. M., Burbank, C. B., and Bellinger, M. J., 1969, Occurrence of painless acute surgical disorders in psychotic patients, N. Engl. J. Med. 206: 580.
Mednick, S. A., 1974, Breakdown in individuals at high risk for schizophrenia: Possible predispositional perinatal factors, in: Genetics, Environment and Psychopathology ( S. A. Mednick, F. Schulsinger, J. Higgins, and B. Bell, eds.), pp. 89–102, Elsevier/NorthHolland, Amsterdam.
Miller, L. H., Kastin, A. J., Sandman, C. A., Fink, M., and van Vien, W. J., 1974, Polypeptide influences in attention, memory, and anxiety in man, Pharmacol. Biochem. Behay. 2: 663.
Mirin, S. M., Meyer, R. E., Mendelson, J. H., and Ellingboe, J., 1980, Opiate use and sexual function, Am. J. Psychiatry 137: 909.
Pradalier, A., Willer, J. C., Boureau, F., and Dry, J., 1980, Pain and Obesity, Lancet 1: 1090.
Sandman, C. A., George, J. M., Nolan, J. D., Van Riezen, H., and Kastin, A. J., 1975, Enhancement of attention in man with ACTH/MSH 4–10, Physiol. Behay. 15: 427.
Sappington, J., 1973, Thresholds of shock-induced discomfort in process and reactive schizophrenics, Percept. Mot. Skills 37: 489.
Spohn, H. E., Lacoursiere, B., Thompson, K., and Coyne, L., 1977, Phenothiazine effects on psychological and psychophysiological dysfunction in chronic schizophrenies, Arch. Gen. Psychiatry 34: 633.
Stein, L., and Belluzzi, J. D., 1978, Brain endorphins and the sense of well-being, in The Endorphins ( E. Costa and M. Trabucchi, eds.), pp. 299–311, Raven Press, New York.
Stein, L., and Belluzzi, J. D., 1979, Brain endorphins: Possible mediators of pleasurable states, in Endorphins in Mental Health Research ( E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.), pp. 375–389, Oxford University Press, London.
Terenius, L., Wahlström, A., Lindström, L. H., and Widerlöv, E., 1976, Increased CSF levels of endorphin in chronic psychosis, Neurosci. Lett. 3: 157.
Terenius, L., Wahlström, A., and Johansson, F., 1979, Endorphins in human cerebrospinal fluid and their measurement, in: Endorphins in Mental Health Research ( E. Usdin, W. E. Bunney, Jr., and N. S. Kline, eds.), pp. 553–560, Oxford University Press, London.
Van Riezen, H., Rigter, H., and de Wied, D., 1977, Possible significance of ACTH fragments for human mental performance, Behay. Biol. 20: 311.
Watson, S. J., Berger, P. A., Akil, H., Mills, M. J., and Barchas, J. D., 1978, Effects of naloxone on schizophrenia: Reduction in hallucinations in a subpopulation of subjects, Science 201: 73.
Author information
Authors and Affiliations
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1982 Plenum Publishing Corporation
About this chapter
Cite this chapter
Davis, G.C., Buchsbaum, M.S., Bunney, W.E. (1982). A Role for Opioid Peptides in Attentional Functioning Clinical Implications. In: Shah, N.S., Donald, A.G. (eds) Endorphins and Opiate Antagonists in Psychiatric Research. Springer, Boston, MA. https://doi.org/10.1007/978-1-4684-1119-5_27
Download citation
DOI: https://doi.org/10.1007/978-1-4684-1119-5_27
Publisher Name: Springer, Boston, MA
Print ISBN: 978-1-4684-1121-8
Online ISBN: 978-1-4684-1119-5
eBook Packages: Springer Book Archive